Pacific Biosciences of California PACB Gross Unrealized Gains
Gross Unrealized Gains at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's gross unrealized gains.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's gross unrealized gains?
- Pacific Biosciences of California (PACB) reported gross unrealized gains of $116K in Q1 2026.
- How has Pacific Biosciences of California's gross unrealized gains changed year-over-year?
- Pacific Biosciences of California's gross unrealized gains decreased by 74.4% year-over-year, from $453K to $116K.
- What is the long-term trend for Pacific Biosciences of California's gross unrealized gains?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's gross unrealized gains has grown at a 205.9% compound annual growth rate (CAGR), from $16K to $458K.